Protease-resistant form of insulin-like growth factor-binding protein 5 is an inhibitor of insulin-like growth factor-I actions on porcine smooth muscle cells in culture.

Overview of attention for article published in Journal of Clinical Investigation, November 1997

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (90th percentile)
High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

patent: 5 patents

Readers on

mendeley: 13 Mendeley

So far, Altmetric has seen 5 patents that reference this research output.

METHOD FOR INHIBITING CELLULAR ACTIVATION BY INSULIN-LIKE GROWTH FACTOR-1

Application WO-2013032948-A1

World Intellectual Property Organisation (WIPO)

07 Mar 2013

Diagnostic methods based on Pregnancy-associated plasma protein-A (PAAP-A)

Application EP-2339020-A1

European Patent Office

29 Jun 2011

Altered insulin-like growth factor binding proteins

Grant US-7488798-B2

United States of America

10 Feb 2009

Modified insulin-like growth factor binding protein

Application JP-2006514535-A

Japan

11 May 2006

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 1 additional patents.